Progress in probiotics for treating Clostridioides difficile infection
10.3760/cma.j.cn112309-20220316-00081
- VernacularTitle:益生菌干预艰难梭菌感染的研究进展
- Author:
Lulu BAI
1
;
Yuanyuan WANG
;
Haoran ZHENG
;
Jiaxin ZHONG
;
Jinxing LU
;
Yuan WU
Author Information
1. 中国疾病预防控制中心传染病预防控制所传染病预防控制国家重点实验室，北京 102206
- Keywords:
Probiotics;
Clostridioides difficile infection;
Intervention;
Multi-omics analysis
- From:
Chinese Journal of Microbiology and Immunology
2022;42(8):652-658
- CountryChina
- Language:Chinese
-
Abstract:
Clostridioides difficile infection (CDI) is an infectious disease with fever, abdominal pain and diarrhea as the main clinical manifestations. At present, CDI is mainly treated with antibiotics and faecal microbiota transplantation. As recurrent and refractory CDI continues to increase, it is important to seek a more effective alternative therapy. However, many of the studies on the prevention and control of CDI by probiotics are still in the early stage. This paper summarized the research on the types, mechanisms and technical means of probiotics in the treatment of CDI.
